Overview OTO-104 for the Treatment of Meniere's Disease Status: Completed Trial end date: 2015-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease. Phase: Phase 2 Details Lead Sponsor: Otonomy, Inc.